Which of the following drug is avoided in patients with diabetes and can be used for treatment of insulinoma?
**Core Concept**
The question is testing the knowledge of medications that affect glucose metabolism and their contraindications in patients with diabetes. The underlying principle is the pharmacological management of diabetes and the treatment of insulinoma, a rare tumor of the pancreas that produces excess insulin.
**Why the Correct Answer is Right**
The correct answer is a drug that can worsen hypoglycemia in patients with diabetes and is used to treat insulinoma by reducing insulin production. This drug works by inhibiting the enzyme that regulates the production of insulin, thereby reducing the risk of hypoglycemia in patients with insulinoma.
**Why Each Wrong Option is Incorrect**
**Option A:** This drug is used to treat type 2 diabetes by increasing insulin sensitivity and is not contraindicated in patients with diabetes.
**Option B:** This drug is used to treat type 2 diabetes by stimulating insulin release and is not contraindicated in patients with diabetes.
**Option C:** This drug is used to treat type 2 diabetes by inhibiting glucagon production and is not contraindicated in patients with diabetes.
**Clinical Pearl / High-Yield Fact**
The Somatostatin analogs, such as Octreotide, can be used to treat insulinoma by inhibiting insulin release, but they can worsen hypoglycemia in patients with diabetes.
**Correct Answer: C. Diazoxide. Diazoxide inhibits insulin release by closing ATP-sensitive potassium channels in the pancreatic beta cells, thereby reducing insulin production and making it useful for the treatment of insulinoma.**